{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:57:46Z","timestamp":1793113066523,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ygyno.2011.02.033","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T01:58:06Z","timestamp":1306202286000},"page":"505-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology"],"prefix":"10.1016","volume":"121","author":[{"given":"K. Ulrich","family":"Petry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Scherbring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Reinecke-L\u00fcthge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"L\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Ordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Regauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.02.033_bb0005","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1470-2045(09)70296-7","article-title":"Trials comparing cytology with human papillomavirus screening","volume":"10","author":"Arbyn","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0025","first-page":"45","article-title":"Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents","volume":"30","author":"Liebrich","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0030","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0035","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-148-7-200804010-00013","article-title":"Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later","volume":"148","author":"Sawaya","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrclinonc.2010.96","article-title":"HPV testing for cervical cancer: the good, the bad, and the ugly","volume":"7","author":"Castle","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0050","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjc.6600918","article-title":"Inclusion of HPV testing in routine cervical cancer screening for women above 29years in Germany: results for 8466 patients","volume":"88","author":"Petry","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test contesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0060","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/AJCPAZV88VIFZSFD","article-title":"High-risk HPV testing in women 30years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up","volume":"133","author":"Thrall","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0065","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","article-title":"New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections","volume":"38","author":"von Knebel Doeberitz","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0070","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0075","doi-asserted-by":"crossref","unstructured":"D. Schmidt, C. Bergeron, KJ. Denton, R. Ridder. p16\/Ki-67 Dual-stained Cytology in the Triage of ASC-US and LSIL Pap Cytology: Results from the European Equivocal or Mildly Abnormal Pap Cytology Study (EEMAPS). Cancer Cytopathol, in press. doi:10.1002\/cncy.20140.","DOI":"10.1002\/cncy.20140"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0080","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1386-6532(09)70294-X","article-title":"Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany\u2014experience over 3years","volume":"46","author":"Luyten","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0085","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system. Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0090","first-page":"175","article-title":"International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy","volume":"101","author":"Walker","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0095","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus versus papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0100","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0105","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0115","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16INK4a overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/AJCP3CD9YKYFJDQL","article-title":"The sensitivity and specificity of p16INK4a cytology vs. HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL Pap cytology results","volume":"134","author":"Denton","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.02.033_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1309\/AJCP6OORTVEZRK7Y","article-title":"Toward objective cervical cancer screening. Maybe the eyes do have it [editorial]","volume":"134","author":"Stoler","year":"2010","journal-title":"Am J Clin Pathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:29:03Z","timestamp":1758770943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0090825811001533"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}